Dr. Casale is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
USF, 12901 Bruce B Downs Blvd
MDC 19
Tampa, FL 33612Phone+1 813-974-8954
Education & Training
- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1982 - 1984
- Graduate School at the National Institutes of HealthNo Degree, 1980 - 1982
- Baylor College of MedicineResidency, Internal Medicine, 1977 - 1980
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1977
- Graduate School in Microbiology, University of Illinois Medical SchoolNo Degree, 1973 - 1974
- University of Illinois at ChicagoB.S., Cum Laude, 1973
Certifications & Licensure
- FL State Medical License 2014 - 2026
- NE State Medical License 1996 - 2014
- IA State Medical License 1984 - 2001
- TX State Medical License 1978 - 1987
- DC State Medical License 1983 - 1984
- MD State Medical License 1983 - 1984
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Creighton University faculty wall of scholarship Creighton University, 2023
- Faculty Outstanding Research Achievement Awards Univ South Florida, 2023
- World’s top 2% most influential scientists and one of the best medicine and immunology scientists in the United States Research.com, 2022-2023
- Join now to see all
Clinical Trials
- Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies Start of enrollment: 2003 Apr 01
- Effect of Xolair on Airway Hyperresponsiveness Start of enrollment: 2004 Jan 01
- Mometasone and Markers of Airway Inflammation Start of enrollment: 2005 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 204 citationsEfficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthmaIoana Agache, Jessica Beltran, Cezmi A. Akdis, Mübeccel Akdis, Carlos Canelo-Aybar
Allergy. 2020-02-08 - 1010 citationsAllergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revisionJan Brozek, Jean Bousquet, Ioana Agache, Arnav Agarwal, Claus Bachert
The Journal of Allergy and Clinical Immunology. 2017-10-01 - 257 citationsNext-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Eval...Jean Bousquet, Holger J. Schünemann, Akdis Togias, Claus Bachert, Martina Erhola
The Journal of Allergy and Clinical Immunology. 2020-01-01
Journal Articles
- Rostrum Harmonization of Terminology for Tolerated and Reactive Dose in Food Allergy ImmunotherapyThomas B Casale, Panida Sriaroon, ScienceDirect
- Ask the Expert Can Xolair Be Used in Nonallergic Asthmatic?Thomas B Casale, Dennis K Ledford, ScienceDirect
- In-Flight Medical EmergenciesCasale TB, Lemanske RF Jr, N Engl J Med, 1/21/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Biomarkers Associated with Response in Patients Initiating Omalizumab: Baseline Levels Among Patients in the Prospective Observational Study to Evaluate Predictors of ...Bradley E. Chipps, William W. Busse, Allan T. Luskin, MD, Robert S. Zeiger, Benjamin Trzaskoma, Hooman Pazwash, Theodore A. Omachi, and Thomas B. Casale, Journal of Allergy and Clinical Immunology, 1/1/2016
- Once-Daily Tiotropium Respimat® Add-on to at Least Ics Maintenance Therapy Demonstrates Improved Asthma Control in Patients with Symptomatic Asthma, Independent of Ser...Mark L. Vandewalker, Johann Christian Virchow, Thomas B. Casale, Michael Engel, Petra Moroni-Zentgraf, Reinhold Luhmann, Ronald Dahl, Journal of Allergy and Clinical Immunology, 1/1/2016
- Tiotropium Respimat® Add-on to at Least Ics Therapy Demonstrates Reduced Risk of Severe Asthma Exacerbation and Asthma Worsening in Symptomatic Asthma, Independent of ...Thomas B. Casale, Donald P. Tashkin, Reinhold Luhmann, Michael Engel, Petra Moroni-Zentgraf, Journal of Allergy and Clinical Immunology, 1/1/2016
- Join now to see all
Lectures
- Plenary: Immunoglobulin E: The First 50 Years and Beyond-Role and Limitations of IgE in Diagnosis and Treatment of Allergic Disease.Los Angeles, CA - 1/1/2016
- Multiallergen vs. single allergen immunotherapy in SLIT vs. SCIT.Palm Beach, FL - 1/1/2016
- Chronic urticaria: New pathophysiologic insights.Palm Beach, FL - 1/1/2016
- Join now to see all
Other
- Clinical Communications Real-World Attitudes Among Allergists/Immunologists Regarding Oral Immunotherapy and Preferred TerminologyThomas Casale, MD, ScienceDirect
https://www.doximity.com/articles/7f90d894-c9f9-4aa2-9628-21b2b51f02b1
UpToDate, Wolters Kluwer Health - 2012-10-22 - Review and Feature Article Emerging Biomarkers and Therapeutic Pipelines for Chronic Spontaneous UrticariaThomas Casale, MD, ScienceDirect
https://www.doximity.com/articles/b65f9083-6415-4836-b6ec-33eae5c35286
UpToDate, Wolters Kluwer Health - 2012-10-24 - The relationship between IgE and allergic disease.Stokes J, Casale TB, Up To Date
1/1/2013 - Join now to see all
Press Mentions
- Dupilumab Proves Effective in Chronic Spontaneous UrticariaOctober 27th, 2024
- Top News of August: FDA Neffy Approval, Women’s Asthma Health, APA-AAI Conference, MoreSeptember 3rd, 2024
- Know All About First FDA Approved Nasal Spray to Treat Severe Allergic ReactionsAugust 12th, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: